Tricyclic therapy of the DSM-III anxiety disorders: A review with implications for further research
Existing data suggests dramatic efficacy for all tested tricyclics in disorders involving spontaneous panic attacks; moderate efficacy for clomipramine but not other tricyclics in obsessive-compulsive patients; possible, but as yet not well established, tricyclic efficacy in generalized anxiety; and...
Gespeichert in:
| Veröffentlicht in: | Journal of psychiatric research 1988, Vol.22, p.7-31 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 31 |
|---|---|
| container_issue | |
| container_start_page | 7 |
| container_title | Journal of psychiatric research |
| container_volume | 22 |
| creator | Liebowitz, Michael R. Fyer, Abby J. Gorman, Jack M. Campeas, Raphael B. Sandberg, Diana P. Hollander, Eric Papp, Lazlo A. Klein, Donald F. |
| description | Existing data suggests dramatic efficacy for all tested tricyclics in disorders involving spontaneous panic attacks; moderate efficacy for clomipramine but not other tricyclics in obsessive-compulsive patients; possible, but as yet not well established, tricyclic efficacy in generalized anxiety; and lack of efficacy in simple phobias. Further studies in all DSM-III Anxiety Disorders are both warranted and required to answer the nonological, pathophysiological and treatment questions raised by these findings. |
| doi_str_mv | 10.1016/0022-3956(88)90067-2 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78463591</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0022395688900672</els_id><sourcerecordid>78463591</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3472-d196cb3d4a5d14c12b1f7a6591b1ab8e0a2ac7dc296d187bd9e2eeae37acc5073</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVoSbdp_kEKOpTQHtzqw7asHAIh_VpI6aHpWYxHY1bBa28kb9P995Wzyx57GsE878voYexCio9SyPqTEEoV2lb1-6b5YIWoTaFO2EI2xhZSG_uCLY7IK_Y6pQchhFGyPGWnWlQ5IBYM72PAHfYB-bSiCJsdH7v5yT__-lEsl0sOw99A0477kMboKaYrfsMj_Qn0xJ_CtOJhvclxmMI4JN6NkXfbOHdlKBFEXL1hLzvoE50f5hn7_fXL_e334u7nt-XtzV2BujSq8NLW2GpfQuVliVK1sjNQV1a2EtqGBChA41HZ2udPtt6SIgLSBhArYfQZu9z3buL4uKU0uXVISH0PA43b5ExT1jrXZbDcgxjHlCJ1bhPDGuLOSeFmt24W52Zxrmncs1uncuztoX_brskfQweZef_usIeE0HcRBgzpiNW20VrPNdd7jLKLrDG6hIEGJB8i4eT8GP5_xz_F-5Xr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78463591</pqid></control><display><type>article</type><title>Tricyclic therapy of the DSM-III anxiety disorders: A review with implications for further research</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Liebowitz, Michael R. ; Fyer, Abby J. ; Gorman, Jack M. ; Campeas, Raphael B. ; Sandberg, Diana P. ; Hollander, Eric ; Papp, Lazlo A. ; Klein, Donald F.</creator><creatorcontrib>Liebowitz, Michael R. ; Fyer, Abby J. ; Gorman, Jack M. ; Campeas, Raphael B. ; Sandberg, Diana P. ; Hollander, Eric ; Papp, Lazlo A. ; Klein, Donald F.</creatorcontrib><description>Existing data suggests dramatic efficacy for all tested tricyclics in disorders involving spontaneous panic attacks; moderate efficacy for clomipramine but not other tricyclics in obsessive-compulsive patients; possible, but as yet not well established, tricyclic efficacy in generalized anxiety; and lack of efficacy in simple phobias. Further studies in all DSM-III Anxiety Disorders are both warranted and required to answer the nonological, pathophysiological and treatment questions raised by these findings.</description><identifier>ISSN: 0022-3956</identifier><identifier>EISSN: 1879-1379</identifier><identifier>DOI: 10.1016/0022-3956(88)90067-2</identifier><identifier>PMID: 3050060</identifier><identifier>CODEN: JPYRA3</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adolescent ; Antidepressive Agents, Tricyclic - therapeutic use ; Anxiety Disorders - drug therapy ; Biological and medical sciences ; Child ; Clomipramine - therapeutic use ; Humans ; Medical sciences ; Neuropharmacology ; Obsessive-Compulsive Disorder - drug therapy ; Panic - drug effects ; Pharmacology. Drug treatments ; Phobic Disorders - drug therapy ; Psycholeptics: tranquillizer, neuroleptic ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology</subject><ispartof>Journal of psychiatric research, 1988, Vol.22, p.7-31</ispartof><rights>1988</rights><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3472-d196cb3d4a5d14c12b1f7a6591b1ab8e0a2ac7dc296d187bd9e2eeae37acc5073</citedby><cites>FETCH-LOGICAL-c3472-d196cb3d4a5d14c12b1f7a6591b1ab8e0a2ac7dc296d187bd9e2eeae37acc5073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0022-3956(88)90067-2$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,4021,27921,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=6983332$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3050060$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liebowitz, Michael R.</creatorcontrib><creatorcontrib>Fyer, Abby J.</creatorcontrib><creatorcontrib>Gorman, Jack M.</creatorcontrib><creatorcontrib>Campeas, Raphael B.</creatorcontrib><creatorcontrib>Sandberg, Diana P.</creatorcontrib><creatorcontrib>Hollander, Eric</creatorcontrib><creatorcontrib>Papp, Lazlo A.</creatorcontrib><creatorcontrib>Klein, Donald F.</creatorcontrib><title>Tricyclic therapy of the DSM-III anxiety disorders: A review with implications for further research</title><title>Journal of psychiatric research</title><addtitle>J Psychiatr Res</addtitle><description>Existing data suggests dramatic efficacy for all tested tricyclics in disorders involving spontaneous panic attacks; moderate efficacy for clomipramine but not other tricyclics in obsessive-compulsive patients; possible, but as yet not well established, tricyclic efficacy in generalized anxiety; and lack of efficacy in simple phobias. Further studies in all DSM-III Anxiety Disorders are both warranted and required to answer the nonological, pathophysiological and treatment questions raised by these findings.</description><subject>Adolescent</subject><subject>Antidepressive Agents, Tricyclic - therapeutic use</subject><subject>Anxiety Disorders - drug therapy</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Clomipramine - therapeutic use</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Obsessive-Compulsive Disorder - drug therapy</subject><subject>Panic - drug effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Phobic Disorders - drug therapy</subject><subject>Psycholeptics: tranquillizer, neuroleptic</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><issn>0022-3956</issn><issn>1879-1379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1r3DAQhkVoSbdp_kEKOpTQHtzqw7asHAIh_VpI6aHpWYxHY1bBa28kb9P995Wzyx57GsE878voYexCio9SyPqTEEoV2lb1-6b5YIWoTaFO2EI2xhZSG_uCLY7IK_Y6pQchhFGyPGWnWlQ5IBYM72PAHfYB-bSiCJsdH7v5yT__-lEsl0sOw99A0477kMboKaYrfsMj_Qn0xJ_CtOJhvclxmMI4JN6NkXfbOHdlKBFEXL1hLzvoE50f5hn7_fXL_e334u7nt-XtzV2BujSq8NLW2GpfQuVliVK1sjNQV1a2EtqGBChA41HZ2udPtt6SIgLSBhArYfQZu9z3buL4uKU0uXVISH0PA43b5ExT1jrXZbDcgxjHlCJ1bhPDGuLOSeFmt24W52Zxrmncs1uncuztoX_brskfQweZef_usIeE0HcRBgzpiNW20VrPNdd7jLKLrDG6hIEGJB8i4eT8GP5_xz_F-5Xr</recordid><startdate>1988</startdate><enddate>1988</enddate><creator>Liebowitz, Michael R.</creator><creator>Fyer, Abby J.</creator><creator>Gorman, Jack M.</creator><creator>Campeas, Raphael B.</creator><creator>Sandberg, Diana P.</creator><creator>Hollander, Eric</creator><creator>Papp, Lazlo A.</creator><creator>Klein, Donald F.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1988</creationdate><title>Tricyclic therapy of the DSM-III anxiety disorders: A review with implications for further research</title><author>Liebowitz, Michael R. ; Fyer, Abby J. ; Gorman, Jack M. ; Campeas, Raphael B. ; Sandberg, Diana P. ; Hollander, Eric ; Papp, Lazlo A. ; Klein, Donald F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3472-d196cb3d4a5d14c12b1f7a6591b1ab8e0a2ac7dc296d187bd9e2eeae37acc5073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adolescent</topic><topic>Antidepressive Agents, Tricyclic - therapeutic use</topic><topic>Anxiety Disorders - drug therapy</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Clomipramine - therapeutic use</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Obsessive-Compulsive Disorder - drug therapy</topic><topic>Panic - drug effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Phobic Disorders - drug therapy</topic><topic>Psycholeptics: tranquillizer, neuroleptic</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liebowitz, Michael R.</creatorcontrib><creatorcontrib>Fyer, Abby J.</creatorcontrib><creatorcontrib>Gorman, Jack M.</creatorcontrib><creatorcontrib>Campeas, Raphael B.</creatorcontrib><creatorcontrib>Sandberg, Diana P.</creatorcontrib><creatorcontrib>Hollander, Eric</creatorcontrib><creatorcontrib>Papp, Lazlo A.</creatorcontrib><creatorcontrib>Klein, Donald F.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of psychiatric research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liebowitz, Michael R.</au><au>Fyer, Abby J.</au><au>Gorman, Jack M.</au><au>Campeas, Raphael B.</au><au>Sandberg, Diana P.</au><au>Hollander, Eric</au><au>Papp, Lazlo A.</au><au>Klein, Donald F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tricyclic therapy of the DSM-III anxiety disorders: A review with implications for further research</atitle><jtitle>Journal of psychiatric research</jtitle><addtitle>J Psychiatr Res</addtitle><date>1988</date><risdate>1988</risdate><volume>22</volume><spage>7</spage><epage>31</epage><pages>7-31</pages><issn>0022-3956</issn><eissn>1879-1379</eissn><coden>JPYRA3</coden><abstract>Existing data suggests dramatic efficacy for all tested tricyclics in disorders involving spontaneous panic attacks; moderate efficacy for clomipramine but not other tricyclics in obsessive-compulsive patients; possible, but as yet not well established, tricyclic efficacy in generalized anxiety; and lack of efficacy in simple phobias. Further studies in all DSM-III Anxiety Disorders are both warranted and required to answer the nonological, pathophysiological and treatment questions raised by these findings.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>3050060</pmid><doi>10.1016/0022-3956(88)90067-2</doi><tpages>25</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-3956 |
| ispartof | Journal of psychiatric research, 1988, Vol.22, p.7-31 |
| issn | 0022-3956 1879-1379 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_78463591 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Adolescent Antidepressive Agents, Tricyclic - therapeutic use Anxiety Disorders - drug therapy Biological and medical sciences Child Clomipramine - therapeutic use Humans Medical sciences Neuropharmacology Obsessive-Compulsive Disorder - drug therapy Panic - drug effects Pharmacology. Drug treatments Phobic Disorders - drug therapy Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology |
| title | Tricyclic therapy of the DSM-III anxiety disorders: A review with implications for further research |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T14%3A01%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tricyclic%20therapy%20of%20the%20DSM-III%20anxiety%20disorders:%20A%20review%20with%20implications%20for%20further%20research&rft.jtitle=Journal%20of%20psychiatric%20research&rft.au=Liebowitz,%20Michael%20R.&rft.date=1988&rft.volume=22&rft.spage=7&rft.epage=31&rft.pages=7-31&rft.issn=0022-3956&rft.eissn=1879-1379&rft.coden=JPYRA3&rft_id=info:doi/10.1016/0022-3956(88)90067-2&rft_dat=%3Cproquest_cross%3E78463591%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78463591&rft_id=info:pmid/3050060&rft_els_id=0022395688900672&rfr_iscdi=true |